Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146488

Pw146488 View Pathway
drug action

Tecovirimat Drug Metabolism Action Pathway

Homo sapiens

PW146853

Pw146853 View Pathway
drug action

Tedizolid Drug Metabolism Action Pathway

Homo sapiens

PW128371

Pw128371 View Pathway
drug action

Tedizolid Phosphate Action Pathway

Homo sapiens
Tedizolid phosphate is an antibiotic, also known as Sivextro, used in the treatment of gram-positive bacterial infections. Tedizolid phosphate is a prodrug and is metabolized in the liver to its active form of Tedizolid. Tedizolid is part of the oxazolidinones class of antibacterials that are capable of inhibiting bacteria that are resistant to other antibiotics. The mechanism of action binds to the A site of the ribosome that interacts with the 23S rRNA subunit, which makes subsequent peptides nonfunctional protein.

PW145934

Pw145934 View Pathway
drug action

Tedizolid phosphate Drug Metabolism Action Pathway

Homo sapiens

PW176143

Pw176143 View Pathway
metabolic

Tedizolid Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Tedizolid are predicted with biotransformer.

PW146050

Pw146050 View Pathway
drug action

Tegafur Drug Metabolism Action Pathway

Homo sapiens

PW146093

Pw146093 View Pathway
drug action

Tegafur-uracil Drug Metabolism Action Pathway

Homo sapiens

PW145170

Pw145170 View Pathway
drug action

Tegaserod Drug Metabolism Action Pathway

Homo sapiens

PW127444

Pw127444 View Pathway
drug action

Teicoplanin Action Pathway

Staphylococcus aureus
Teicoplanin is a glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria. It is used for the treatment of bacterial infections caused by susceptible microorganisms. It is a glycopeptide antiobiotic extracted from Actinoplanes teichomyceticus, with a similar spectrum of activity to vancomycin. Its mechanism of action is to inhibit bacterial cell wall synthesis. Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death. Oral teicoplanin has been demonstrated to be effective in the treatment of pseudomembranous colitis and Clostridium difficile-associated diarrhoea, with comparable efficacy to vancomycin. Teicoplanin is poorly absorbed after oral administration but is 90% bioavailable when administered intramuscularly.

PW145661

Pw145661 View Pathway
drug action

Teicoplanin Drug Metabolism Action Pathway

Homo sapiens